Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain-Guided balance training: a new frontier in fall prevention?

NCT ID NCT07739056

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether a personalized rehabilitation program, tailored to an individual's brain and movement patterns, can reduce fall risk in adults aged 65 and older. Participants will first undergo assessments of brain activity, cognitive function, and balance. High-risk individuals will then be randomly assigned to either the personalized program or standard fall-prevention exercises, attending sessions 2-3 times a week for 8-12 weeks. The study will track falls over several months to see if the personalized approach leads to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Personalized neurophysiological rehabilitation
What this could lead to
If successful, this could lead to a more effective, tailored approach to preventing falls in older adults, potentially reducing injuries and improving independence.
What could go wrong
This is an early-stage trial with a small number of participants, so results may not apply to everyone. The personalized program is complex and may not prove more effective than standard exercise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must meet all of the following criteria: * Age ≥ 65 years * Community-dwelling * Ability to ambulate independently (with or without assistive device) * Ability to understand instructions and provide informed consent Participants will be stratified into fall-risk categories based on established criteria: * High fall risk: history of ≥1 fall in the previous 12 months and/or impaired functional performance (e.g., TUG \> 13.5 s or BBS ≤49) * Low/no fall risk: no falls and preserved functional mobility These criteria are consistent with previously published fall-prevention trials. Exclusion Criteria: * Participants will be excluded if they have: * Neurological conditions affecting gait or balance (e.g., stroke, Parkinson's disease) * Severe musculoskeletal disorders limiting mobility * Severe cognitive impairment (e.g., inability to follow instructions or MoCA \< 18) * Uncontrolled cardiovascular or metabolic conditions * Current participation in structured rehabilitation programs * Contraindications to EEG, EMG, or fNIRS measurements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Accidental falls/prevention & control are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Sharjah

    Sharjah city, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.